Healthcare provider profile · identity verified

Kim Joseph Van Guilder, M.D.

Internal Medicine · PALM SPRINGS, CA · NPI 1457593006

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1040	400
Rosuvastatin Calcium	Rosuvastatin Calcium	492	181
Losartan Potassium	Losartan Potassium	464	188
Lisinopril	Lisinopril	448	168
Levothyroxine Sodium	Levothyroxine Sodium	431	163
Amlodipine Besylate	Amlodipine Besylate	412	167
Meloxicam	Meloxicam	329	125
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	321	103
Atenolol	Atenolol	271	104
Albuterol Sulfate Hfa	Albuterol Sulfate	259	124
Furosemide	Furosemide	256	87
Tamsulosin Hcl	Tamsulosin Hcl	255	92
Omeprazole	Omeprazole	239	100
Trazodone Hcl	Trazodone Hcl	238	72
Pradaxa	Dabigatran Etexilate Mesylate	224	86
Simvastatin	Simvastatin	219	82
Hydrochlorothiazide	Hydrochlorothiazide	198	75
Metformin Hcl	Metformin Hcl	195	78
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	189	67
Metformin Hcl Er	Metformin Hcl	188	69
Gabapentin	Gabapentin	182	69
Pantoprazole Sodium	Pantoprazole Sodium	179	72
Metoprolol Tartrate	Metoprolol Tartrate	176	70
Acyclovir	Acyclovir	164	61
Alendronate Sodium	Alendronate Sodium	163	64
Potassium Chloride	Potassium Chloride	139	65
Finasteride	Finasteride	136	52
Allopurinol	Allopurinol	121	46
Triamcinolone Acetonide	Triamcinolone Acetonide	116	59
Metoprolol Succinate	Metoprolol Succinate	113	44
Glipizide	Glipizide	110	45
Terazosin Hcl	Terazosin Hcl	108	40
Clopidogrel	Clopidogrel Bisulfate	105	47
Tramadol Hcl	Tramadol Hcl	104	36
Carvedilol	Carvedilol	102	45
Jardiance	Empagliflozin	98	45
Pravastatin Sodium	Pravastatin Sodium	96	35
Ibuprofen	Ibuprofen	89	42
Eliquis	Apixaban	82	22
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	81	22
Duloxetine Hcl	Duloxetine Hcl	77	23
Hydralazine Hcl	Hydralazine Hcl	77	25
Spiriva Respimat	Tiotropium Bromide	77	27
Ozempic	Semaglutide	75	22
Humulin N	Insulin Nph Human Isophane	70	21
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	68	34
Lorazepam	Lorazepam	65	22
Testosterone	Testosterone	64	24
Ondansetron Odt	Ondansetron	63	17
Fluoxetine Hcl	Fluoxetine Hcl	61	23
Escitalopram Oxalate	Escitalopram Oxalate	60	20
Sertraline Hcl	Sertraline Hcl	60	24
Famotidine	Famotidine	59	28
Montelukast Sodium	Montelukast Sodium	57	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	55	26
Prednisone	Prednisone	53	39
Venlafaxine Hcl Er	Venlafaxine Hcl	53	16
Doxycycline Monohydrate	Doxycycline Monohydrate	52	20
Ezetimibe	Ezetimibe	52	22
Mirtazapine	Mirtazapine	50	16
Sumatriptan Succinate	Sumatriptan Succinate	49	14
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	48	13
Wixela Inhub	Fluticasone Propion/Salmeterol	48	23
Acetaminophen-Codeine	Acetaminophen With Codeine	47	26
Azelastine Hcl	Azelastine Hcl	47	12
Glipizide-Metformin	Glipizide/Metformin Hcl	45	16
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	43	40
Mupirocin	Mupirocin	43	30
Alvesco	Ciclesonide	42	23
Cephalexin	Cephalexin	42	39
Bupropion Xl	Bupropion Hcl	41	13
Zolpidem Tartrate	Zolpidem Tartrate	41	13
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	40	40
Alprazolam	Alprazolam	40	19
Tizanidine Hcl	Tizanidine Hcl	40	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	39	15
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	38	13
Humulin R	Insulin Regular, Human	38	11
Citalopram Hbr	Citalopram Hydrobromide	37	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	17
Terbinafine Hcl	Terbinafine Hcl	36	11
Azithromycin	Azithromycin	35	30
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	35	22
Pregabalin	Pregabalin	35	14
Humulin N Kwikpen	Insulin Nph Human Isophane	34	13
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Temazepam	Temazepam	34	14
Glipizide Er	Glipizide	31	12
Propranolol Hcl	Propranolol Hcl	31	15
Nystatin	Nystatin	29	11
Spironolactone	Spironolactone	29	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Bupropion Hcl Sr	Bupropion Hcl	28	suppressed
Lactulose	Lactulose	28	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	26	26
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	17
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	26	25
Lovastatin	Lovastatin	26	suppressed
Fenofibrate	Fenofibrate	25	11
Ketoconazole	Ketoconazole	25	15
Ondansetron Hcl	Ondansetron Hcl	25	suppressed
Ibandronate Sodium	Ibandronate Sodium	24	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Morphine Sulfate Er	Morphine Sulfate	24	suppressed
Nitroglycerin	Nitroglycerin	24	15
Clobetasol Propionate	Clobetasol Propionate	23	12
Oxycodone Hcl	Oxycodone Hcl	23	suppressed
Colchicine	Colchicine	22	11
Nortriptyline Hcl	Nortriptyline Hcl	22	suppressed
Sucralfate	Sucralfate	22	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Brilinta	Ticagrelor	20	suppressed
Digoxin	Digoxin	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Baclofen	Baclofen	18	suppressed
Diazepam	Diazepam	18	suppressed
Fluticasone Propionate	Fluticasone Propionate	18	11
Hydrocortisone	Hydrocortisone	18	14
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	15
Tadalafil	Tadalafil	18	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	16	suppressed
Amoxicillin	Amoxicillin	15	11
Cartia Xt	Diltiazem Hcl	15	12
Cholestyramine	Cholestyramine (With Sugar)	15	suppressed
Clonazepam	Clonazepam	15	suppressed
Divalproex Sodium	Divalproex Sodium	15	suppressed
Estradiol	Estradiol	15	suppressed
Fluocinonide	Fluocinonide	15	suppressed
Gavilyte-C	Peg3350/Sod Sulf,bicarb,cl/Kcl	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Mesalamine	Mesalamine	14	suppressed
Morphine Sulfate	Morphine Sulfate	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Retin-A	Tretinoin	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Acarbose	Acarbose	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Erythromycin	Erythromycin Base	13	12
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Clindamycin Hcl	Clindamycin Hcl	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Naproxen	Naproxen	12	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	11	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Potassium Citrate Er	Potassium Citrate	11	suppressed
Victoza 2-Pak	Liraglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error